Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT00409435
PHASE2

A Study of Pyridostigmine in Postural Tachycardia Syndrome

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This is a 3-day study comparing pyridostigmine versus placebo in the treatment of postural tachycardia syndrome (POTS). The researchers expect pyridostigmine to improve tachycardia and stabilize blood pressure.

Official title: Double-Blind, Placebo-Controlled Study of Pyridostigmine in Postural Tachycardia Syndrome

Key Details

Gender

All

Age Range

15 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2006-10

Completion Date

2027-02

Last Updated

2026-03-05

Healthy Volunteers

No

Interventions

DRUG

pyridostigmine

one 180 mg capsule per day for 3 days

DRUG

Placebo

one capsule per day for 3 days

Locations (1)

Mayo Clinic

Rochester, Minnesota, United States